Autosomal dominant inheritance of cardiac valves anomalies in two families: Extended spectrum of left-ventricular outflow tract obstruction

American Journal of Medical Genetics, Part A

Volumn 149, Issue 2, 2009, Pages 216-225

  Wessels, Marja W ^a   Van De Laar, Ingrid M B H ^a   Roos Hesselink, Jolien ^a   Strikwerda, Sipke ^b   Majoor Krakauer, Danielle F ^a   De Vries, Bert B A ^c   Kerstjens Frederikse, Wilhelmina S ^d   Vos, Yvonne J ^d   De Graaf, Bianca M ^a   Bertoli Avella, Aida M ^a   Willems, Patrick J ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Genetic Diagnostics Belgium   (Belgium)

Author keywords

Aortic dilatation; Autosomal dominant; Bicuspid aortic valve; Candidate genes; Congenital heart malformation; Heart valves; Left ventricular outflow tract obstruction; Pathways; Thoracic aortic aneurysm

Indexed keywords

ADULT; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BICUSPID AORTIC VALVE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE FAILURE; HEART MURMUR; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MALE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; NEWBORN; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; PULMONARY VALVE DISEASE; PULMONARY VALVE INSUFFICIENCY; SCHOOL CHILD; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

FAMILY HEALTH; GENES, DOMINANT; HEART SEPTAL DEFECTS, VENTRICULAR; HEART VALVES; HUMANS; PENETRANCE; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 59849083527     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32594     Document Type: Article

References (111)

1. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers E. 2002. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129:4613-4625.
2. Akiyama H, Chaboissier MC, Behringer RR, Rowitch DH, Schedl A, Epstein JA, de Crombrugghe B. 2004. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci USA 101:6502-6507.
3. Armstrong EJ, Bischoff J. 2004. Heart valve development: Endothelial cell signaling and differentiation. Circ Res 95:459-470.
4. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, Elliott DA, Barnett L, Koentgen F, Robb L, Feneley M, Harvey RP. 2000. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx 2-5. Circ Res 87:888-895.
5. Bonnet D, Fermont L, Kachaner J, Sidi D, Amiel J, Lyonnet S, Munnich A. 1999. Tricuspid atresia and conotruncal malformations in five families. J Med Genet 36:349-350.
6. Bruneau BG. 2008. The developmental genetics of congenital heart disease. Nature 451:943-948.
7. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A Jr, Kubalak S, Klewer SE, McDonald JA. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106:349-360.
8. Chen B, Bronson RT, Klaman LD, Hampton TG, Wang JF, Green PJ, Magnuson T, Douglas PS, Morgan JP, Neel BG. 2000. Mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 24:296-299.
9. Chitayat D, McIntosh N, Fouron JC. 1992. Pulmonary atresia with intact ventricular septum and hypoplastic right heart in sibs: A single gene disorder? Am J Med Genet 42:304-306.
10. Ciuffo AA, Cunningham E, Traill TA. 1985. Familial pulmonary valve stenosis, atrial septal defect, and unique electrocardiogram abnormalities. J Med Genet 22:311-313.
11. Clementi M, Notari L, Borghi A, Tenconi R. 1996. Familial congenital bicuspid aortic valve: A disorder of uncertain inheritance. Am J Med Genet 62:336-338.
12. Coblentz B, Mathivat A. 1952. Stenose pulmonaire congenitale chez deux soeurs. Arch Mal Coeur 5:490-495.
13. Costello M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, Munoz-Chapuli R. 2002. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 91:158-164.
14. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A. 2006. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 38:452-457.
15. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M. 2004. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol 271:263-271.
16. Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. 2004. Bicuspid aortic valve is heritable. J Am Coll Cardiol 44:138-143.
17. Crispino JD, Lodish MB, Thurberg BL, Litovsky SH, Collins T, Molkentin JD, Orkin SH. 2001. Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev 15:839-844.
18. David TJ. 1974. A family with congenital pulmonary valve stenosis. Humangenetik 21:287-288.
19. Delot EC, Bahamonde ME, Zhao M, Lyons KM. 2003. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 130:209-220.
20. DiChiara JA, Pieroni DR, Gingell RL, Bannerman RM, Vlad P. 1980. Familial pulmonary atresia. Its occurrence with a ventricular septal defect. Am J Dis Child 134:506-508.
21. Donovan J, Kordylewska A, Jan YN, Utset MF. 2002. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 12:1605-1610.
22. Elliott DA, Kirk EP, Yeoh T, Chandar S, McKenzie F, Taylor P, Grossfeld P, Fatkin D, Jones O, Hayes P, Feneley M, Harvey RP. 2003. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol 41:2072-2076.
23. Ellison JW, Yagubyan M, Majumdar R, Sarkar G, Bolander ME, Atkinson EJ, Sarano ME, Sundt TM. 2007. Evidence of genetic locus heterogeneity for familial bicuspid aortic valve. J Surg Res 142:28-31.
24. El-Said GM, El-Guindy M, Ibrahim MM, El-Sherif AA. 1979. Familial valvular pulmonic stenosis involving three siblings. Cardiovasc Dis 6:50-54.
25. Emanuel R, Withers R, O'Brien K, Ross P, Feizi O. 1978. Congenitally bicuspid aortic valves: Clinicogenetic study of 41 families. Br Heart J 40:1402-1407.
26. Erickson SL, O'Shea KS, Ghaboosi N, Loverro L, Frantz G, Bauer M, Lu LH, Moore MW. 1997. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2-and heregulin-deficient mice. Development 124:4999-5011.
27. Eronen M, Peippo M, Hiippala A, Raatikka M, Arvio M, Johansson R, Kahkonen M. 2002. Cardiovascular manifestations in 75 patients with Williams syndrome. J Med Genet 39:554-558.
28. Fischer A, Steidl C, Wagner TU, Lang E, Jakob PM, Friedl P, Knobeloch KP, Gessler M. 2007. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 100:856-863.
29. Freed LA, Acierno JS Jr, Dai D, Leyne M, Marshall JE, Nesta F, Levine RA, Slaugenhaupt SA. 2003. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 72:1551-1559.
30. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone MA Jr, Falb D, Huszar D. 2000. A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24:171-174.
31. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424:443-447.
32. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. 2006. Mutations in NOTCH1 cause aortic valve disease. Nature 437:270-274.
33. Gaussin V, Van de Putte T, Mishina Y, Hanks MC, Zwijsen A, Huylebroeck D, Behringer RR, Schneider MD. 2002. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci USA 99:2878-2883.
34. Gill HK, Splitt M, Sharland GK, Simpson JM. 2003. Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol 42:923-929.
35. Glick BN, Roberts WC. 1994. Congenitally bicuspid aortic valve in multiple family members. Am J Cardiol 73:400-404.
36. Goh D, Han L, Judge DP, Geutbner J, McIntosh I, Patel A, Thomas G, Basson CT, Milewicz DM, Dietz H. 2002. Linkage of familial bicuspid aortic valve with aortic aneurysm to chromosome15q [abstract 239]. Presented at the annual meeting of the American society of human genetics.
37. Grant JW. 1996. Congenital malformations of the tricuspid valve in siblings. Pediatr Cardiol 17:327-329.
38. Grossfeld PD, Lucas VW, Sklansky MS, Kashani IA, Rothman A. 1997. Familial occurrence of pulmonary atresia with intact ventricular septum. Am J Med Genet 72:294-296.
39. Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, Amor D, Ades L, McConnell V, Willoughby CE, Abuelo D, Willing M, Lewis RA, Kim DH, Scherer S, Tung PP, Ahn C, Buja LM, Raman CS, Shete SS, Milewicz DM. 2007. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39:1488-1493.
40. Hallaq H, Pinter E, Enciso J, McGrath J, Zeiss C, Brueckner M, Madri J, Jacobs HC, Wilson CM, Vasavada H, Jiang X, Bogue CW. 2004. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development 131:5197-5209.
41. Hanada K, Vermeij M, Garinis GA, de Waard MC, Kunen MG, Myers L, Maas A, Duncker DJ, Meijers C, Dietz HC, Kanaar R, Essers J. 2007. Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circ Res 100:738-746.
42. Hinton RB Jr, Martin LJ, Tabangin ME, Mazwi ML, Cripe LH, Benson DW. 2007. Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol 50:1590-1595.
43. Huntington K, Hunter AG, Chan KL. 1997. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 30:1809-1812.
44. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, Patterson C, Lee DC. 2003. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22:2704-2716.
45. Katz SG, Williams A, Yang J, Fujiwara Y, Tsang AP, Epstein JA, Orkin SH. 2003. Endothelial lineage-mediated loss of the GATA cofactor friend of GATA 1 impairs cardiac development. Proc Natl Acad Sci USA 100:14030-14035.
46. Kim RY, Robertson EJ, Solloway MJ. 2001. Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev Biol 235:449-466.
47. Klinge T, Laursen HB. 1975. Familial pulmonary stenosis with underdeveloped or normal right ventricle. Br Heart J 37:60-64.
48. Kokubo H, Miyagawa-Tomita S, Tomimatsu H, Nakashima Y, Nakazawa M, Saga Y, Johnson RL. 2004. Disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circ Res 95:540-547.
49. Krantz ID, Smith R, Colliton RP, Tinkel H, Zackai EH, Piccoli DA, Goldmuntz E, Spinner NB. 1999. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet 8:56-60.
50. Kumai M, Nishii K, Nakamura K, Takeda N, Suzuki M, Shibata Y. 2000. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 127:3501-3512.
51. Kumar A, Victorica BE, Gessner IH, Alexander JA. 1994. Tricuspid atresia and annular hypoplasia: Report of a familial occurrence. Pediatr Cardiol 15:201-203.
52. Kurohara K, Komatsu K, Kurisaki T, Masuda A, Irie N, Asano M, Sudo K, Nabeshima Y, Iwakura Y, Sehara-Fujisawa A. 2004. Essential roles of Meltrin beta (ADAM19) in heart development. Dev Biol 267:14-28.
53. Kyndt F, Schott JJ, Trochu JN, Baranger F, Herbert O, Scott V, Fressinaud E, David A, Moisan JP, Bouhour JB, Le Marec H, Benichou B. 1998. Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet 62:627-632.
54. Kyndt F, Gueffet JP, Probst V, Jaafar P, Legendre A, Le Bouffant F, Toquet C, Roy E, McGregor L, Lynch SA, Newbury-Ecob R, Tran V, Young I, Trochu JN, Le Marec H, Schott JJ. 2007. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 115:40-49.
55. Lakkis MM, Epstein JA. 1998. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125:4359-4367.
56. Lamy M, de Grouchy J, Schweisguth O. 1957. Genetic and non-genetic factors in the etiology of congenital heart disease: A study of 1188 cases. Am J Hum Genet 9:17-41.
57. Lee TC, Zhao YD, Courtman DW, Stewart DJ. 2000. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 101:2345-2348.
58. Lewin MB, McBride KL, Pignatelli R, Fernbach S, Combes A, Menesses A, Lam W, Bezold LI, Kaplan N, Towbin JA, Belmont JW. 2004. Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions. Pediatrics 114:691-696.
59. Liebner S, Cattelino A, Gallini R, Rudini N, Iurlaro M, Piccolo S, Dejana E. 2004. Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 166:359-367.
60. Lin AE, Rosti L. 1998. Tricuspid atresia in sibs. J Med Genet 35:1055-1056.
61. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, Izpisua-Belmonte JC, Rosenfeld MG. 1999. Pitx2 regulates lung asymmetry, cardiac positioning, and pituitary and tooth morphogenesis. Nature 401:279-282.
62. Lincoln J, Alfieri CM, Yutzey KE. 2004. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn 230:239-250.
63. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, Backer JD, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. 2005. A syndrome of altered cardiovascular,craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275-281.
64. Loffredo CA. 2000. Epidemiology of cardiovascular malformations: Prevalence and risk factors. Am J Med Genet 97:319-325.
65. Loscalzo ML, Goh DL, Loeys B, Kent KC, Spevak PJ, Dietz HC. 2007. Familial thoracic aortic dilation and bicommissural aortic valve: A prospective analysis of natural history and inheritance. Am J Med Genet A 143A:1960-1967.
66. Majumdar R, Yagubyan M, Sarkar G, Bolander ME, Sundt TM III. 2006. Bicuspid aortic valve and ascending aortic aneurysm are not associated with germline or somatic homeobox NKX2-5 gene polymorphism in 19 patients. J Thorac Cardiovasc Surg 131:1301-1305.
67. Maron BJ, Hutchins GM. 1974. The development of the semilunar valves in the human heart. Am J Pathol 74:331-344.
68. Martin LJ, Ramachandran V, Cripe LH, Hinton RB, Andelfinger G, Tabangin M, Shooner K, Keddache M, Benson DW. 2007. Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations. Hum Genet 121:275-284.
69. McBride KL, Pignatelli R, Lewin M, Ho T, Fernbach S, Menesses A, Lam W, Leal SM, Kaplan N, Schliekelman P, Towbin JA, Belmont JW. 2005. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: Segregation, multiplex relative risk, and heritability. Am J Med Genet 134:180-186.
70. McCarron WE, Perloff JK. 1974. Familial congenital valvular pulmonic stenosis. Am Heart J 88:357-359.
71. McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, Spinner NB. 2006. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 79:169-173.
72. McDonald K, Maurer BJ. 1989. Familial aortic valve disease: Evidence for a genetic influence? Eur Heart J 10:676-677.
73. McElhinney DB, Krantz ID, Bason L, Piccoli DA, Emerick KM, Spinner NB, Goldmuntz E. 2002. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106:2567-2574.
74. McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. 2003. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42:1650-1655.
75. Menahem S. 1990. Familial aggregation of defects of the left-sided structures of the heart. Int J Cardiol 29:239-240.
76. Metcalfe K, Rucka AK, Smoot L, Hofstadler G, Tuzler G, McKeown P, Siu V, Rauch A, Dean J, Dennis N, Ellis I, Reardon W, Cytrynbaum C, Osborne L, Yates JR, Read AP, Donnai D, Tassabehji M. 2000. Elastin: Mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet 8:955-963.
77. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. 1998. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202:56-66.
78. Mo FE, Lau LF. 2006. The matricellular protein CCN1 is essential for cardiac development. Circ Res 99:961-969.
79. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003. Dysregulation of tgf-[beta] activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407-411.
80. Nesta F, Leyne M, Yosefy C, Simpson C, Dai D, Marshall JE, Hung J, Slaugenhaupt SA, Levine RA. 2005. New locus for autosomal dominant mitral valve prolapse on chromosome 13: Clinical insights from genetic studies. Circulation 112:2022-2030.
81. Newbury-Ecob RA, Zuccollo JM, Rutter N, Young ID. 1993. Sex linked valvular dysplasia. J Med Genet 30:873-874.
82. Norris RA, Moreno-Rodriguez RA, Sugi Y, Hoffman S, Amos J, Hart MM, Potts JD, Goodwin RL, Markwald RR. 2008. Periostin regulates atrioventricular valve maturation. Dev Biol 316:200-213.
83. Puri MC, Partanen J, Rossant J, Bernstein A. 1999. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 126:4569-4580.
84. Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186-190.
85. Ransom J, Srivastava D. 2007. The genetics of cardiac birth defects. Semin Cell Dev Biol 18:132-139.
86. Rao SS, Gootman N, Platt N. 1969. Familial aortic atresia. Report of a case of aortic atresia in siblings. Am J Dis Child 118:919-922.
87. Robbins JR, McGuire PG, Wehrle-Haller B, Rogers SL. 1999. Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissues of the Patch mutant mouse: Regulation of MMP-2 by PDGF and effects on mesenchymal cell migration. Dev Biol 212:255-263.
88. Robinson SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, Steiner RD, Maslen CL. 2003. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 72:1047-1052.
89. Sarkozy A, Conti E, Esposito G, Pizzuti A, Dallapiccola B, Mingarelli R, Marino B, Digilio MC, Paoletti V. 2003. Nonsyndromic pulmonary valve stenosis and the PTPN11 gene. Am J Med Genet A 116A:389-390.
90. Schroeder JA, Jackson LF, Lee DC, Camenisch TD. 2003. Form and function of developing heart valves: Coordination by extracellular matrix and growth factor signaling. J Mol Med 81:392-403.
91. Schunkert H, Brockel U, Kromer EP, Elsner D, Jacob HJ, Riegger GA. 1997. A large pedigree with valvuloseptal defects. Am J Cardiol 80:968-970.
92. Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W, Wagner EF. 2003. Mice humanized for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 130:4515-4525.
93. Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M, Harvey RP, Martinez AC, Mackay CR, Mackay F. 2007. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 104:14759-14764.
94. Stephen LJ, Fawkes AL, Verhoeve A, Lemke G, Brown A. 2007. A critical role for the EphA3 receptor tyrosine kinase in heart development. Dev Biol 302:66-79.
95. Svensson EC, Huggins GS, Lin H, Clendenin C, Jiang F, Tufts R, Dardik FB, Leiden JM. 2000. A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nature Genet 25:353-356.
96. Sznajer Y, Keren B, Baumann C, Pereira S, Alberti C, Elion J, Cave H, Verloes A. 2007. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene. Pediatrics 119:1325-1331.
97. Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, Takamoto S, Hirata Y, Nagai R. 2005. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol 46:134-141.
98. Tevosian SG, Deconinck AE, Tanaka M, Schinke M, Litovsky SH, Izumo S, Fujiwara Y, Orkin SH. 2000. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101:729-739.
99. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares JM, Diez J, Aranda S, Palomo S, McCormick F, Izpisua-Belmonte JC, de la Pompa JL. 2004. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18:99-115.
100. Udwadia AD, Khambadkone S, Bharucha BA, Lokhandwala Y, Irani SF. 1996. Familial congenital valvar pulmonary stenosis: Autosomal dominant inheritance. Pediatr Cardiol 17:407-409.
101. Van den Akker NM, Winkel LC, Nisancioglu MH, Maas S, Wisse LJ, Armulik A, Poelmann RE, Lie-Venema H, Betsholtz C, Gittenberger-de Groot AC. 2008. PDGF-B signaling is important for murine cardiac development: Its role in developing atrioventricular valves, coronaries, and cardiac innervation. Dev Dyn 237:494-503.
102. Wang B, Weidenfeld J, Lu MM, Maika S, Kuziel WA, Morrisey EE, Tucker PW. 2004. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development 131:4477-4487.
103. Weismann CG, Gelb BD. 2007. The genetics of congenital heart disease: A review of recent developments. Curr Opin Cardiol 22:200-206.
104. Wessels MW, Berger RM, Frohn-Mulder IM, Roos-Hesselink JW, Hoogeboom JJ, Mancini GS, Bartelings MM, Krijger RD, Wladimiroff JW, Niermeijer MF, Grossfeld P, Willems PJ. 2005. Autosomal dominant inheritance of left ventricular outflow tract obstruction. Am J Med Genet A 134A:171-179.
105. Winnier G, Blessing M, Labosky PA, Hogan BL. 1995. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116.
106. Winnier GE, Kume T, Deng K, Rogers R, Bundy J, Raines C, Walter MA, Hogan BL, Conway SJ. 1999. Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles. Dev Biol 213:418-443.
107. Ya J, Schilham MW, de Boer PA, Moorman AF, Clevers H, Lamers WH. 1998. Sox4-deficiency syndrome in mice is an animal model for common trunk. Circ Res 83:986-994.
108. Yamazaki S, Iwamoto R, Saeki K, Asakura M, Takashima S, Yamazaki A, Kimura R, Mizushima H, Moribe H, Higashiyama S, Endoh M, Kaneda Y, Takagi S, Itami S, Takeda N, Yamada G, Mekada E. 2003. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 163:469-475.
109. Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda S, Clouthier DE, Yanagisawa M. 2000. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 105:1373-1382.
110. Yoshioka M, Yuasa S, Matsumura K, Kimura K, Shiomi T, Kimura N, Shukunami C, Okada Y, Mukai M, Shin H, Yozu R, Sata M, Ogawa S, Hiraki Y, Fukuda K. 2006. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med 12:1151-1159.
111. Zhou HM, Weskamp G, Chesneau V, Sahin U, Vortkamp A, Horiuchi K, Chiusaroli R, Hahn R, Wilkes D, Fisher P, Baron R, Manova K, Basson CT, Hempstead B, Blobel CP. 2004. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol 24:96-104.